The relationship between CT assessed lung damage, and inflammatory markers in exhaled breath condensate of cystic fibrosis patients
C. Robroeks, M. Roozeboom, P. de Jong, Q. Jöbsis, S. Robben, H. Tiddens, W. Wodzig, J. Damoiseaux, A. Bast, J. B. Yntema, H. Brackel, E. Dompeling (Maastricht, Amersfoort, Rotterdam, Nijmegen, Eindhoven, Veldhoven, Netherlands)
Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Robroeks, M. Roozeboom, P. de Jong, Q. Jöbsis, S. Robben, H. Tiddens, W. Wodzig, J. Damoiseaux, A. Bast, J. B. Yntema, H. Brackel, E. Dompeling (Maastricht, Amersfoort, Rotterdam, Nijmegen, Eindhoven, Veldhoven, Netherlands). The relationship between CT assessed lung damage, and inflammatory markers in exhaled breath condensate of cystic fibrosis patients. Eur Respir J 2007; 30: Suppl. 51, 348
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
NO metabolites in exhaled breath condensate in cystic fibrosis patients: correlation with pulmonary function, nutritional status and systemic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 715s Year: 2006
Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases Source: Annual Congress 2009 - Lung function in adults and children Year: 2009
MicroRNA-26a expression in exhaled breath condensate correlates with pulmonary exacerbation in cystic fibrosis Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2020
Clinically relevant early functional and diagnostic markers of lung disease in children Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=120 Year: 2006
Increased IL-8 in exhaled breath condensate in cystic fibrosis during acute exacerbation Source: Eur Respir J 2001; 18: Suppl. 33, 537s Year: 2001
Is NO2/X index useful for evaluation of oxidative stress in exhaled breath condensate in cystic fibrosis? Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008
Exhaled breath condensate markers in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 334s Year: 2005
Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF Source: Eur Respir J 2006; 28: Suppl. 50, 353s Year: 2006
Exhaled pentane – a new breath test in cystic fibrosis? Source: Annual Congress 2006 - New developments in infant and intensive care lung function Year: 2006
Conductivity in exhaled breath condensate of patients with asthma, COPD or cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 227s Year: 2005
Epithelial alarmin levels in exhaled breath condensate in patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018
Inflammatory markers in exhaled breath condensate, assessed by means of Luminex® technology, can differentiate between children with asthma, cystic fibrosis and healthy controls Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007
The clinical significance of growth factors measurement in exhaled breath condensates (EBC) among patients with interstitial lung diseases Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010
Myeloperoxidase in exhaled breath condensate reflects the status of lung parenchyma during the exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 54s Year: 2005
Relationship between acidity of exhaled breath condensate, lung function and airway inflammation in asthmatic children Source: Annual Congress 2007 - Assessing asthma severity and control in children Year: 2007
The relationships between markers of inflammation in exhaled breath condensate and bronchoalveolar lavage in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 307s Year: 2004
Inflammatory markers in exhaled breath condensate in bronchiectasis Source: Eur Respir J 2004; 24: Suppl. 48, 707s Year: 2004
Association of exhaled breath condensate pH with markers of neutrophilic inflammation in bronchoalveolar lavage in young children with cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010
Cytokines in exhaled breath condensate of children with asthma and cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 468s Year: 2004
Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008